Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
The “Only Healthcare” podcast reveals shocking truths about the healthcare industry. Why are US Healthcare costs and risks so high? How will new technologies impact the system? What are the challenges in accessing new therapies and treatments? What is happening with Big Pharma and how do they influence other stakeholders in healthcare? Hosted by industry experts Michael Navin and Dr. Randy Vogenberg, to provide you with actionable and inspirational insights on how we can improve healthcare cost, care and accessibility for all.
Hosted by:
Michael Navin & Dr. Randy Vogenberg
Michael's LinkedIn
https://www.linkedin.com/in/michael-navin-7411388/
Randy's LinkedIn
https://www.linkedin.com/in/randyvogenberg/
Sponsored by:
Only Healthcare is sponsored by Peek and the Institute for Integrated Health.
Peek: Peek is reimagining access through innovation, technology, connectivity, and partnership. Peek offers a comprehensive and unique suite of solutions to help clients improve access and affordability for prescription drugs.
The Peek Meds Marketplace is one of Peek’s differentiated offerings that gives employers a revolutionary new approach to controlling runaway prescription costs for their employees by providing unprecedented transparency, simplicity - and cost savings. The Peek Meds Marketplace aggregates cash discount cards, manufacturer copay offset programs, and an employee’s insurance information to provide a holistic and personalized view of prescription price options. This easy-to-use platform offers a one-stop-shopping experience for prescription drugs.
Peek’s team has decades of experience in the pharmaceutical industry and offers various services to biopharma manufacturers, brokers, benefits consultants, third-party administrators and employers. Visit peekmeds.com to learn more.
Institute for Integrated Health (IIH):
Healthcare benefits, insurance coverage regulations, and business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provide strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning, and advisory on market trends and U.S. healthcare market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. Learn more by visiting https://iih-online.com/.
Music by:
Hanu Dixit, https://www.youtube.com/hanudixit
Disclaimer:
© 2025 Only Healthcare Podcast. All rights reserved.
This podcast and its content, including but not limited to audio recordings, images, and text, are the property of the Only Healthcare Podcast and are protected by international copyright laws. We appreciate all distribution and content sharing. Contact us at onlyhealthcarepodcast@gmail.com to access our media kits, provide feedback or inquire about guest participation. Thank you for listening.
| Episode | Date |
|---|---|
|
EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?
|
Feb 26, 2026 |
|
Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?
|
Feb 19, 2026 |
|
Ep 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing
|
Feb 12, 2026 |
|
Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change
|
Feb 05, 2026 |
|
Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy
|
Jan 29, 2026 |
|
Ep 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, and Engagement
|
Jan 22, 2026 |
|
Ep 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026
|
Jan 15, 2026 |
|
Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds
|
Jan 08, 2026 |
|
Ep 34 | ACNU Explained: How FDA’s New Nonprescription Pathway Could Expand Access and Improve Adherence
|
Jan 06, 2026 |
|
Ep 33 | Year in Review: The Healthcare Shifts That Defined 2025 and What’s Ahead in 2026
|
Dec 29, 2025 |
|
Ep 32 | Exploring AI Patient Care and Clinical Decision Making with Carole Tremonti
|
Dec 22, 2025 |
|
Ep 31 | The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next
|
Dec 15, 2025 |
|
Ep 30 | ACNU Live Panels Follow-Up: Deep Dive Virtual Panel On FDA’s New ACNU Rule
|
Dec 08, 2025 |
|
Ep 29 | The Future of the Journal of Clinical Pathways with Winston Wong
|
Nov 24, 2025 |
|
Ep 28 | Insights from Health Rosetta Fest 2025
|
Nov 17, 2025 |
|
Ep 27 | Nicholas Hall Panel Discussion 2: Nonprescription Access to Drug Treatment
|
Nov 11, 2025 |
|
EP 26 | OHPLive! Non prescription access to drug treatment
|
Nov 10, 2025 |
|
Breaking Down the $80 Billion 340B Drug Program with William Sarraille | Only Healthcare Podcast #25
|
Sep 25, 2025 |
|
How Cell and Gene Therapies Can Bankrupt Unprepared Employers with Tom Sondergeld | Only Healthcare Podcast #24
|
Sep 18, 2025 |
|
Healthcare’s Lightning Strike Cost Problem with Drew Wilkins | Only Healthcare Podcast #23
|
Sep 11, 2025 |
|
The Hidden Agenda of Healthcare Insurance with Tamara Thomas | Only Healthcare Podcast #22
|
Aug 21, 2025 |
|
Breaking the Healthcare Monopoly with Dave Chase and Steve Ditto | Only Healthcare Podcast #21
|
Aug 01, 2025 |
|
GLP-1s: The Billion Dollar Dilemma in US Healthcare with Deborah Williams | Only Healthcare Podcast #20
|
Jul 24, 2025 |
|
Why Are Prescription Drugs So Expensive with Michael Navin & Dr. Randy Vogenberg | Only Healthcare Podcast #19
|
Jul 10, 2025 |
|
Why the US Spends the Most on Healthcare But Gets the Worst Outcomes with Dr. Randy Vogenberg & Michael Navin | Only Healthcare Podcast #18
|
Jun 19, 2025 |
|
Secrets to Solutions: How Real-Time Pricing Data Can Heal Healthcare
|
May 20, 2025 |
|
Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?
|
Apr 18, 2025 |
|
Confronting the Affordability Crisis: Unmasking the True Cost of Healthcare
|
Mar 20, 2025 |
|
Clear Costs, Clearer Choices: Unpacking Trump’s Transparency Drive in Healthcare
|
Mar 03, 2025 |
|
Policy and Power: Dismantling Middleman Dominance in Healthcare
|
Feb 27, 2025 |
|
Rethinking Risk: Innovating Benefit Design for Whole-Person Care
|
Feb 14, 2025 |
|
Navigating the Future of Healthcare Policy
|
Jan 28, 2025 |
|
Transforming Healthcare: Innovations in Clinical Pathways with Dr. Randy Vogenberg
|
Jan 09, 2025 |
|
What Can Be Done to Bridge the Gap Between Employer-Manufacturer Collaboration
|
Nov 21, 2024 |
|
Unlocking Access and Collaboration: The Benefits of Employer-Pharma Relationships
|
Nov 07, 2024 |
|
How Employer-Pharmaceutical Collaboration Can Transform Healthcare Plans
|
Oct 24, 2024 |
|
Navigating State-Level Legislation & The Future of Patient-Centered Care
|
Oct 16, 2024 |
|
Ask The Expert with Michael Navin: Unpacking the Latest Prescription Lawsuits
|
Sep 27, 2024 |
|
GLP-1 Drugs: Rapid Growth and Market Evolution
|
Sep 15, 2024 |
|
Ask the Expert with Dr. Randy Vogenberg: How Government Policies Influence Commercial Insurance Implications
|
Aug 22, 2024 |
|
How Employer Decisions Impact Coverage & Reimbursement
|
Aug 12, 2024 |
|
Exploring Healthcare Stakeholder Interactions
|
Jul 10, 2024 |